LRP1B and hepatocellular carcinoma: Based on the sequencing data of liver tumors from TCGA and next-generation sequencing (NGS) data of 657 liver tumors from Chinese clinical dataset, Wang and colleagues claimed that LRP1B contributed to 12.3% of HCC patients with mutated gene in the Chinese cohort [20], which is similar to the results here (shown in Figure 1A).